Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 19/20 | 0.52 |
| ▸ | FKBP5 | Q13451 | 4/20 | 0.43 |
| ▸ | FKBP4 | Q02790 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7803438 | 0.78 | FKBP1A (0.67) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL5700670 | 0.75 | FKBP1A (0.44) | FKBP1A | |
| SCHEMBL5966055 | 0.74 | FKBP1A (0.49) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL5965922 | 0.73 | FKBP1A (0.53) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL5700683 | 0.73 | FKBP1A (0.44) | FKBP1A | |
| SCHEMBL7424334 | 0.73 | FKBP1A (0.64) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL5700583 | 0.72 | FKBP1A (0.53) | FKBP1A | |
| SCHEMBL5965992 | 0.71 | FKBP1A (0.57) | FKBP1AFKBP5FKBP4 | |
| SCHEMBL5966154 | 0.71 | FKBP1A (0.45) | FKBP1A | |
| SCHEMBL5966022 | 0.69 | FKBP1A (0.52) | FKBP1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0777478-B1 | INHIBITORS OF ROTAMASE ENZYME ACTIVITY | GUILFORD PHARM INC (US) | 2001-11-07 | — | — | EP | claimed |
| US-20010036947-A1 | Pipecolic acid derivative hair growth compositions and uses | GPI NIL HOLDINGS, INC. (US) | 2001-11-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010036947-A1 | Pipecolic acid derivative hair growth compositions and uses | PIP5K1C, PIP4K2C, PIP5K1A | FKBP1A 510/4885FKBP5 730/4885FKBP4 1140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.